EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Red Blood Cell Membrane‐Coated Nanoparticles Enable Incompatible Blood Transfusions

Xuewei Yang, Mengchun Chen, Cuiye Weng, Deli Zhuge, Fangsi Jin, Yingnan Xiao, Dongyan Tian, Qingqing Yin, Li Li, Xufei Zhang, Genghe Shi, Xiaosheng Lu und 8 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202310230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Xuewei Yang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China. Hauptthemen laut MEDLINE: Nanoparticles, Erythrocyte Membrane. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Natural Science Foundation, Key Projects Jointly Constructed by Zhejiang Province and the Ministry, Major Innovation Project of Wenzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood transfusions save lives and improve health every day. Despite the matching of blood types being stricter than it ever has been, emergency transfusions among incompatible blood types are still inevitable in the clinic when there is a lack of acceptable blood types for recipients. Here to overcome this, a counter measure nanoplatform consisting of a polymeric core coated by a red blood cell (RBC) membrane is developed. With A‐type or B‐type RBC membrane camouflaging, the nanoplatform is capable of specifically capturing anti‐A or anti‐B IgM antibodies within B‐type or A‐type whole blood, thereby decreasing the corresponding IgM antibody levels and then allowing the incompatible blood transfusions. In addition to IgM, the anti‐RBC IgG antibody in a passive immunization murine model can likewise be neutralized by this nanoplatform, leading to prolonged circulation time of incompatible donor RBCs. Noteworthily, nanoplatform made by expired RBCs (>42 days stored hypothermically) and then subjected to lyophilization does not impair their effect on antibody neutralization. Most importantly, antibody‐captured RBC‐NP do not exacerbate the risk of inflammation, complement activation, and coagulopathy in an acute hemorrhagic shock murine model. Overall, this biomimetic nanoplatform can safely neutralize the antibody to enable incompatible blood transfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesErythrocyte MembraneAnimalsMiceBlood TransfusionDisease Models, AnimalHumansErythrocytesBlood Group Incompatibility

Stichwörter der Autor:innen

antibodybiomimetic nanoparticlecell membraneincompatible blood transfusionneutralization

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • Department of Pharmaceutics, School of Pharmaceutical Sciences of Wenzhou Medical University, Wenzhou, 325035, China.
  • Department of Pediatric Allergy and Immunology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • Department of Blood Transfusion, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
  • Wenzhou Medical University, Wenzhou, 325027, China.

ORCID-Profile: Yijie Chen

Förderung

  • Zhejiang Natural Science Foundation
  • Key Projects Jointly Constructed by Zhejiang Province and the Ministry
  • Major Innovation Project of Wenzhou Science and Technology Bureau
  • Key Project of Ningbo Science and Technology Bureau
  • Project of Zhejiang Natural Science Foundation
  • Youth Fund Project of Zhejiang Natural Science Foundation

Zitieren

APA

Yang, X., Chen, M., Weng, C., Zhuge, D., Jin, F., Xiao, Y., Tian, D., Yin, Q., Li, L., Zhang, X., Shi, G., Lu, X., Yan, L., Wang, L., Wen, B., Zhao, Y., Lin, J., Wang, F., Zhang, W., & Chen, Y. (2024). Red Blood Cell Membrane‐Coated Nanoparticles Enable Incompatible Blood Transfusions. Advanced Science. https://doi.org/10.1002/advs.202310230

Vancouver

Yang X, Chen M, Weng C, Zhuge D, Jin F, Xiao Y, et al. Red Blood Cell Membrane‐Coated Nanoparticles Enable Incompatible Blood Transfusions. Advanced Science. 2024. doi:10.1002/advs.202310230

BibTeX
@article{Yang2024,
  author = {Yang, Xuewei and Chen, Mengchun and Weng, Cuiye and Zhuge, Deli and Jin, Fangsi and Xiao, Yingnan and Tian, Dongyan and Yin, Qingqing and Li, Li and Zhang, Xufei and Shi, Genghe and Lu, Xiaosheng and Yan, Linzhi and Wang, Ledan and Wen, Bin and Zhao, Yingzheng and Lin, Jiajin and Wang, Fang and Zhang, Weixi and Chen, Yijie},
  title = {Red Blood Cell Membrane‐Coated Nanoparticles Enable Incompatible Blood Transfusions},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202310230}
}
Kostenlos starten →